|
GTX21532
| GeneTex International Corporation |
Paraffin Tissue Array, Liver (Muliple Species)
| | | |
|
GTX21521
| GeneTex International Corporation |
Human Tissue Array - Liver Tumor (70 cases + 5 normal)
| | | |
|
GTX21520
| GeneTex International Corporation |
Human Tissue Array - Liver Tumor (70 cases + 5 normal)
| | | |
|
LV809a
| US Biomax |
Hepatocellular carcinoma array with liver tissue, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing LV809
| | | |
|
LV208
| US Biomax |
Liver cancer (hepatocellular carcinoma) and normal tissue high density (69 cases/208 cores) tissue microarray, with stage and grade info
| | | |
|
LV20810
| US Biomax |
Liver cancer survey tissue array (2 of 3), with normal tissue, including TNM and pathology grade, 208 cases/208 cores
| | | |
|
LV20811
| US Biomax |
Liver cancer survey tissue array (3 of 3), with normal tissue, including TNM and pathology grade, 208 cases/208 cores
| | | |
|
LV2083
| US Biomax |
High-density liver cancer tissue array with normal tissues, with stage and grade info, 69 cases/208 cores
| | | |
|
LV2089
| US Biomax |
Liver cancer survey tissue array (1 of 3), with normal tissue, including TNM and pathology grade, 208 cases/208 cores
| | | |
|
LV2161
| US Biomax |
Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 216 cases/216 cores
| | | |
|
OD-CT-DgLivT10-024
| US Biomax |
Liver cancer tissue array with biochemical indicators (AFP, HBV, HCV RNA, Creatinine, Urea nitrogen, CEA), 49 cases. 41 cases have tumor and matched normal adjacent tissue.
| | | |
|
LV803a
| US Biomax |
Liver carcinoma (combination of adjacent normal, cancer and cancer adjacent tissue), including TNM and pathology grade, 54cases/ 72 cores, replacing LV803
| | | |
|
LV805b
| US Biomax |
Hepatic tissue, hepatitis and hepatic cirrhosis tissue array, 80 cases/80 cores, replacing LV805a
| | | |
|
HLivH060CD03
| US Biomax |
Hepatocellular carcinoma tissue microarray, 40 cases/60 cores, progression clincal stage I - IV.
| | | |
|
HLiv-HCC180Sur-05
| US Biomax |
Hepatocellular carcinoma tissue array, 95 cases. Tumor and normal adjacent tissue.
| | | |
|
LV6161
| US Biomax |
High-density liver cancer array, with clinical stage, pathology grade and normal hepatic tissue, 322 cases/616 cores
| | | |
|
OD-CT-DgLiv01-012
| US Biomax |
Hepatocellular carcinoma tissue array, 55 cases. 51 cases have tumor and matched normal adjacent tissue, 4 cases have tumor or NAT
| | | |
|
HLiv-HCC180Sur-03
| US Biomax |
Liver cancer tissue array, 90 cases, and normal adjacent tissue, 1 core/case, with survival data
| | | |
|
HLiv-HCC180Sur-04
| US Biomax |
Hepatocellular carcinoma tissue array, clinical stage I-III, 90 cases. Tumor and normal adjacent tissue. With survival data.
| | | |
|
HLiv-HCC180Sur-02
| US Biomax |
HLiver cancer tissue array, 90 cases of tumor and matched normal adjacent tissue, 1 core/case, with survival data
| | | |